Skip to content

A Study to See the Effect of Dexmedetomidine Given Before Removal of Breathing Tube on Heart Rate, Blood Pressure and Recovery After Surgery Compared to Placebo

To study the effect of Dexmedetomidine on hemodynamic and recovery response during tracheal extubation; a randomised double blinded controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109491
Enrollment
74
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Use of dexmedetomidine for extubation response attenuation: injection dexmedetomidine 0.5mcg/kg infusion in 100ml NS over 10 minutes around 15 minutes before planned tracheal extubation

Sponsors

PACIFIC MEDICAL COLLEGE AND HOSPITAL UDAIPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA(American Society of Anesthesiologists) Grade-I and Grade-II Patient willing to give written informed consent patients undergoing elective surgery under general anesthesia with endotracheal intubation and planned for post operative extubation

Exclusion criteria

Exclusion criteria: Patients posted for emergency surgeries patients with Known hypersensitivity or allergy to any drug used in study Patient refusal to written informed consent Patients belonging to ASA grade-III or above patients having Difficult airway (Mallampati score III and IV) Patients requiring postoperative mechanical ventilation Patients with Baseline bradycardia (heart rate patients with Hypotension (systolic blood pressure Pregnant or lactating women Obesity (body mass index > 30 kg/m ) Patients with significant respiratory disease or with recent upper respiratory tract infection Patients with significant hepatic or renal dysfunction Patients with significant cardiovascular disease Patients receiving medications affecting heart rate or blood pressure

Design outcomes

Primary

MeasureTime frame
evaluating the effect of dexmedetomidine 0.5mcg/kg to attenuate the hemodynamic parameters and recovery characteristics during tracheal extubation Timepoint: evaluating the effect of dexmedetomidine 0.5mcg/kg to attenuate the hemodynamic parameters and recovery characteristics 1 minute before drug administration , during drug administration at 3,7,10 minutes , 1 minute pre-extubation ,at the time of extubation and post-extubation at 2,6,8,10 minutes

Secondary

MeasureTime frame
To document side effects During & post drug administration if anyTimepoint: at drug administration & at 3 minutes 7 minutes 10 minutes post extubation;Emergence time from stopping anesthetic to eye opening & Extubation quality scoring during extubationTimepoint: after stopping anesthetic drug, 1 minute before extubation & at time of extubation 0 minute & post extubation at 1 minute 3 minute;to document modified ramsay sedation scoreTimepoint: at the time of extubation 0minute & post extubation 1 minute 5 minutes 10 minutes 15 minutes & 30 minutes;to document timeline for recovery that is modified aldrete scoreTimepoint: 5 minutes 10 minutes 15 minutes after extubation then every 15 minutes until aldrete score is equal to or more than 9

Countries

India

Contacts

Public ContactDr Ravindra Singh Chouhan

Pacific Medical College and Hospital, udaipur

raviaiims777@gmail.com9663579407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026